Notes
2017 US dollars
Reference
Gharaibeh M, et al. Economic Evaluation for USA of Systemic Chemotherapies as First-Line Treatment of Metastatic Pancreatic Cancer. PharmacoEconomics : 9 Jun 2018. Available from: URL: https://doi.org/10.1007/s40273-018-0678-6
Rights and permissions
About this article
Cite this article
Gemcitabine regimens cost effective for pancreatic cancer. PharmacoEcon Outcomes News 806, 13 (2018). https://doi.org/10.1007/s40274-018-5056-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-5056-2